Oroxin A Induces Autophagic Cell Death in Gastric Cancer Cells Through the MAPK/ERK/REDD1 Axis
Cell Biology International · 2025
DOI: 10.1002/cbin.70092 ↗At a glance
Journal article in Cell Biology International, 2025. Written by Linen Li and 6 co-authors. Institution: Department of Gastroenterology, Jiangxi Provincial Key Laboratory of Digestive Diseases, Jiangxi Clinical Research Center for Gastroenterology, Diges…. Major MEDLINE topics: Stomach Neoplasms, Autophagic Cell Death, MAP Kinase Signaling System, Transcription Factors. 43 references. Funded by: This study was supported by the Double-Thousand Plan of Jiangxi Province (No. jxsq2023201044) and National Natural Science Foundation of China (No. 82360119)..
Abstract (original language)
Gastric cancer (GC) is one of the most prevalent malignant tumors worldwide, with limited treatment efficacy and high drug resistance. Natural compounds offer promising therapeutic potential due to their multitarget and low‐toxicity profiles. This study aimed to explore the anticancer effects of Oroxin A (OA), a natural flavonoid, and its underlying mechanisms in gastric cancer. A series of in vitro assays and organoid models were used to assess OA's effects on cell viability, proliferation, and migration. Mechanistic investigations included RNA‐sequencing, Western blot analysis, immunofluorescence, and electron microscopy. OA significantly inhibited gastric cancer cell growth and migration while showing minimal toxicity to normal gastric epithelial cells. OA induced autophagic, rather than apoptotic, cell death. Mechanistically, OA activated the MAPK/ERK signaling pathway, upregulated REDD1, and inhibited mTOR signaling, leading to enhanced autophagy. REDD1 overexpression amplified this effect, whereas knockdown reversed it. OA induces autophagic cell death in gastric cancer cells via the MAPK/ERK/REDD1 pathway, providing a promising natural compound candidate for gastric cancer therapy.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Gastroenterology, Jiangxi Provincial Key Laboratory of Digestive Diseases, Jiangxi Clinical Research Center for Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital, Jiangxi Medical…
- Postdoctoral Innovation Practice Base, The First Affiliated Hospital of Nanchang University, Nanchang, China.
ORCID profiles: Xu Shu
Funding
- This study was supported by the Double-Thousand Plan of Jiangxi Province (No. jxsq2023201044) and National Natural Science Foundation of China (No. 82360119).
Cite
APA
Li, L., Rong, J., Liao, F., Shangguan, J., Xie, C., Zhu, Y., & Shu, X. (2025). Oroxin A Induces Autophagic Cell Death in Gastric Cancer Cells Through the MAPK/ERK/REDD1 Axis. Cell Biology International. https://doi.org/10.1002/cbin.70092
Vancouver
Li L, Rong J, Liao F, Shangguan J, Xie C, Zhu Y, et al. Oroxin A Induces Autophagic Cell Death in Gastric Cancer Cells Through the MAPK/ERK/REDD1 Axis. Cell Biology International. 2025. doi:10.1002/cbin.70092
BibTeX
@article{Li2025,
author = {Li, Linen and Rong, Jianfang and Liao, Foqiang and Shangguan, Jianfang and Xie, Chuan and Zhu, Yin and Shu, Xu},
title = {Oroxin A Induces Autophagic Cell Death in Gastric Cancer Cells Through the MAPK/ERK/REDD1 Axis},
journal = {Cell Biology International},
year = {2025},
doi = {10.1002/cbin.70092}
}
EUVIMED